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Abstract
Bacteria of the genus Staphylococcus are important human and veterinary pathogens. 
A crucial characteristic for this group of bacteria is that they can easily acquire mecha-
nisms of antibiotic resistance for a plethora of antibiotics currently in use for human 
and animal therapies. Therefore, there is a great need to find novel, non-antibiotic che-
motherapeutics with marked antistaphylococcal activity. Promising but still underesti-
mated group of potential antistaphylococcal chemotherapeutics constitute bee products: 
honey, pollen, royal jelly, fermented pollen and especially propolis. Another group of 
natural products that exhibit promising antibacterial activity is essential oils. Usefulness 
of bee products and essential oils in the treatment of infections caused by S. aureus has 
been confirmed by results of many investigations carried out by researches in different 
regions of the world. In this chapter, we have presented the review of publication in this 
area as well as perspectives and limitations of future applications of these two groups of 
natural products.
Keywords: Staphylococcus aureus, resistance, bee products, honey, propolis, pollen, 
fermented pollen, essential oils
1. Introduction
1.1. Staphylococci: important human and veterinary pathogens
Staphylococcus aureus is a species of bacteria commonly found in many ecological niches i.e., 
in soil, water and public places. These bacteria also colonize the skin and mucosal surfaces 
of humans and also several animal species. The most important site of S. aureus coloniza-
tion is anterior nares of the nose, but these bacteria are also often isolated from the pharynx, 
perineum and axilla [1–3]. It was revealed in several independent studies that persistent 
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 colonization with S. aureus is observed in approximately 20% of human population, about 
30% carry these microorganisms transiently and 50% are non-carriers [3–5]. S. aureus simi-
larly as several other species of the genus Staphylococcus are classified as commensal Gram-
positive bacteria. Like other commensal microorganisms, staphylococci have the ability to 
cause disease under certain conditions. It should be noted, however, that S. aureus is defi-
nitely one of the most dangerous commensal bacteria which colonize any part of the human 
body. Its high pathogenicity is based on production of a wide array of virulence factors such 
as protein A, coagulase, collagenase, hyaluronidase, hemolysins, lipases, multiple toxins, 
adhesive proteins and also proteins involved in biofilm formation. The ability to express 
these virulence factors has been confirmed not only for clinical isolates of S. aureus, but also 
for strains isolated from animal sources, e.g. bovine mastitis [6, 7] and food [8, 9]). All these 
isolates are potentially dangerous human pathogens. S. aureus has also developed several 
mechanisms that enable them escape from protective immune responses of infected humans 
or animals. Among them, protein A (SpA), staphylokinase and staphylococcal binder of 
immunoglobulin are the most important and the best characterized [10]. Another crucial 
characteristic for this group of bacteria is that they can easily acquire mechanisms of antibi-
otic resistance for a plethora of antibiotics currently in use for human and animal therapies. 
Especially important problem is rapidly growing number of isolation of strains resistant to 
methicillin, designated as Methicillin Resistant Staphylococcus aureus (MRSA). MRSA isolates 
are resistant to all β-lactam antibiotics. Moreover, some of them are classified as multidrug 
resistant (MDR)—not susceptible to the antibiotics that belong to various chemical groups. 
The MDR phenotype is usually associated with strains recovered from medical environ-
ment—Healthcare Associated MRSA (HA-MRSA). The drugs of choice for treatment of MRSA 
infections are glycopeptides, mainly vancomycin. Unfortunately, staphylococci developed 
also resistance to this group of antibiotics, and prevalence of isolation of vancomycin-inter-
mediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) strains is constantly 
growing. The number of other antibiotics, which could be used for eradication of HA-MRSA 
infections, is very limited. In fact, only three antibiotics recently introduced to routine medi-
cine procedures are effective in treatment of HA-MRSA infections: from the oxazolidinone 
group—linezolid; streptogramin group—quinupristin/dalfopristin, and from the glycyl-
cycline group—tigecycline [11–13]. HA-MRSA are also usually susceptible to rifampicin, 
fusidic acid and co-trimoxazole; however, the last one does not give results good enough in 
treatment of acute infections, and in the case of two other drugs, resistance is easily acquired 
by treated bacteria [12–14]. The problem regarding therapy of staphylococci-related infec-
tions is additionally enhanced by the staphylococcal ability to form biofilm. Some of the 
previous studies proved that the biofilm-forming bacteria (including S. aureus) may be in 
fact 10–1000 times more resistant to antimicrobial agents than the same cells growing in a 
planktonic manner [15, 16].
Staphylococci also belong to the most important animal pathogens. Infections caused by these 
bacteria leads to huge economic losses in agriculture and food industry. Contamination of 
food products by these bacteria is a serious issue due to their completely lack of susceptibility 
to lysozyme and very low susceptibility to nisin, two important agents used as preservatives 
in food industry [17, 18].
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1.2. Natural products as potential antimicrobial agents
All presented above aspects (the prevalence of the staphylococci in the environment, their 
high virulence potential and first of all rapid increase in antibiotic resistance) clearly indicate 
that there is an urgent need to develop new, effective inexpensive and not covered by current 
existing mechanisms of resistance antistaphylococcal agents. Interesting groups of antimicro-
bials, which meet all these expectations and could be used for treatment of S. aureus human 
and animal infections, but also for protection of food products against contamination by these 
bacteria, are bee products (honey, propolis, pollen, bee bread and royal jelly) and obtained 
from a broad spectrum of plant sources, essential oils (EO). Both these groups of products 
should be classified as well-known but rarely used antimicrobial agents. For centuries, herbs, 
bee products, venoms of some of animals (snakes and spiders) and other natural products 
were the only medicines that people knew and used. In some cases, the effects of the so-called 
folk/traditional medicine were surprisingly good, also in the case of therapy of infections. 
Unfortunately, from the beginning of “antibiotic era”, they were nearly completely eliminated 
from clinical. One of the most spectacular examples of successful application of natural prod-
ucts for treatment infections is discovered by Prof. Tu Youyou, artemisinin. Artemisinin and 
its semi-synthetic derivatives exhibit the most rapid action against Plasmodium falciparum and 
are now standard treatment worldwide for P. falciparum malaria. For the discovery of arte-
misinin, Professor Youyou received the Prize of Nobel in 2015. The success of Prof. Youyou 
clearly confirms the high therapeutic potential of natural products, and it is also a good occa-
sion for promotion of other natural products that exhibit antimicrobial activity but in fact are 
nearly completely forgotten, or rather eliminated, from clinical practice.
The main purpose of the preparation of this chapter is to demonstrate that bee and plant 
products are still interesting and promising group of antimicrobials. Their antibacterial activ-
ity is not only a matter of history from the pre-antibiotic era. Their large antimicrobial poten-
tial was confirmed with modern microbiological methods and analytical techniques and is 
well-documented in many scientific publications.
2. Antimicrobial activity of bee products
2.1. Honey
2.1.1. Basic information and mechanisms of antimicrobial activity
From ancient times, honey was a very valued component of the diet. This is mainly due to 
its characteristic sweet taste. The main uses of honey are as follows: as a spread on bread, a 
sweetener for tea, milk and coffee, for preparing desserts and cakes. Recently, it has been also 
proposed to use honey as a component of healthy, high energetic, beverages. The sweet taste 
of honey is apparent from its chemical composition. Sugars, mainly fructose and glucose, 
and minor amounts of oligosaccharides account for about 80% of its weight. The centuries of 
observations have also shown that regular consumption of honey is beneficial to the health 
of consumer. Therefore, this product was widely used as drug in traditional medicine, one 
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of the most important except of herbs. The research carried out during several last decades 
finally confirmed that honey (and also other bee products) is a beneficial agent in treatment 
of a wide spectrum of human diseases, such as some cardiovascular and gastrointestinal tract 
disorders, infections within upper respiratory tract including cough, as well as in healing of 
infected wounds [19]. While folk medicine was based only on tradition and experience, the 
achievements of modern science and medicine have found confirmation of the therapeutic 
potential of honey, as the consequence of its chemical composition. It has been revealed that 
crucial for therapeutic properties of honey are its non-sugar components such as: enzymes, 
peptides, free amino acids, vitamins, organic acids, flavonoids, phenolic acids and other phy-
tochemicals, minerals [20]. Especially interesting subject seems to be its antimicrobial activity. 
As it was mentioned above, this product was successfully used in treatment of skin and soft 
tissue infections and for elimination of pathogens infecting mucosal of respiratory tract. In all 
these situations, physical contact of honey (its components) with infected tissue (microorgan-
isms infecting the tissue) is possible. The antimicrobial action of honey is based on several 
mechanisms: the acidity (low pH, usually in the range from 3.4 to 6.1), osmotic pressure of 
sugars present in honey and the presence of bacteriostatic and bactericidal substances such 
as H
2
O
2
, antioxidants, lysozyme, polyphenols, phenolic acids, flavonoids, methylglyoxal and 
bee peptides [21–24]. The crucial component that is responsible for the antimicrobial activity 
of majority of the honey types is hydrogen peroxide, which is formed as a side product of the 
oxidation of glucose by glucose oxidase—the enzyme which is introduced to the honey from 
the salivary glands of bees. Interestingly glucose oxidase is inactive in non-diluted honey [25]. 
The inhibition of growth of bacteria in honey, at the original concentration of this product, 
is mainly caused by high concentration of sugars (high osmotic pressure) coupled with high 
acidity [21, 22]. Therefore, it can be stored for long period of time (at least 2 years) without 
any additional treatment or supplementation with preservatives. When honey is diluted to 
certain extent, its antibacterial activity is shifted from osmotic- and pH-dependent to perox-
ide-dependent mechanism of action based on the generation of H
2
O
2
 [26]. This scenario takes 
place when honey is used for treatment of infections, e.g. infected wound. On the basis of 
current state of knowledge, it can be said that other mentioned above components of honey, 
mainly phytochemicals, seem to only support the antibacterial effect of generated H
2
O
2
. The 
dominant role of the enzyme in the antimicrobial activity of several polish unifloral honeys 
was recently confirmed in the researches that were carried out in our group. Preincubation 
of honeys solutions in 80°C for only 10 min resulted in complete loss of antibacterial activ-
ity of all tested honeys. The same effect was observed when suspensions of tested bacterial 
cells in solutions of honeys were supplemented with catalase. In both cases the observed, 
complete losses of activity of honeys were the consequence of lack of possibilities for H
2
O
2
 
generation. Heat treatment resulted in denaturation of the enzyme, and in the presence of 
catalase, the generated hydrogen peroxide was immediately decomposed [27]. On the other 
hand, antimicrobial activity of honey also depends on the botanical source which was used by 
bees to collect the nectar. Buckwheat, thyme and cornflower honeys usually exhibit high anti-
microbial activity, whilst produced in Poland in large amounts rape honey do not affect the 
growth of neither Gram-positive nor Gram-negative bacteria [27, 28]. Thus, the types of phy-
tochemicals as well their concentration is important for final antimicrobial potential of honey. 
The issue of role of phytochemicals in the antimicrobial potential of honey is still not clear 
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and is a subject of many interesting research. Hydrogen peroxide is also a known cytostatic 
agent; however, its concentration in honey is on a very low level which is safe for humans 
and animals. According to Lusby et al. [29], the concentration of H
2
O
2
 in honey is thousand 
times lower than in the common 3% antiseptic solution available in pharmacies; however, its 
constant production causes prolonged activity which can be considered as an advantage. The 
concentration of hydrogen peroxide on a non-toxic and stable level is probably regulated by 
antioxidants and pollen-derived catalase which destroy excess amounts of H
2
O
2
 [30].
2.1.2. Honey as a potential antistaphylococcal agent
The results of many investigations, carried out in different geographical regions of the world, 
revealed especially high efficiency of honey in treatment of infections caused by Gram-
positive microorganisms, e.g. staphylococci. The mentioned above investigation carried out 
in our group revealed that honeys obtained from some species of plants, namely cornflower 
(Centaurea cyanus L.), buckwheat (Fagopyrum esculentum Moench) and thyme (Thymus vulgaris 
L.) were able to inhibit the growth of reference strain S. aureus PCM 2051 at the concentration 
of 3.12 or 6.25% (v/v). Satisfactory activity (minimal inhibitory concentration—MIC ≥6.25%) 
was observed for honeys obtained from linden tree (Tilia spp.), heather (Calluna vulgaris 
L.), savory (Satureja hortensis L.) and coriander (Coriandrum sativum L.). Other tested bacte-
ria Staphylococcus epidermidis PCM 2118 and especially Pseudomonas aeruginosa ATCC 27853 
and Escherichia coli K12 were less susceptible [27]. Quite similar results were obtained in the 
research carried out by the other polish group that investigates antimicrobial potential of bee 
products. Buckwheat, linden tree and heather honeys were found very active. Moreover, the 
authors also revealed high activity of goldenrod honey (Solidago spp.)—that was not observed 
in our research and honeydew honey—not investigated in our research. The latter is a specific 
kind of honey produced by bees, which collect the honeydew, the sweet secretions of aphids 
or other plant sap-sucking insects [28]. The observed in our studies activity against S. aureus 
was similar to the activity exerted by Slovenian chestnut, fir honeydew and forest honey 
(MIC = 2.5%, v/v) reported by Kuncic and coworkers [31] as well as Chilean Ulmo tree honey 
(MIC = 3.1%, v/v) reported by group of Sherlock [32]. The MIC values (against S. aureus) in 
the range of concentrations from 3.12 to 12.5% (v/v) were also observed by Anthimidou and 
Mossialos, who investigated a collection of 31 Greek and Cypriot honeys, they also revealed 
that Gram-negative bacteria P. aeruginosa revealed a bit higher resistance with MICs values in 
the range from 6.25 to 25% (v/v) [33]. Lallam and coworkers investigated antibacterial poten-
tial of 32 samples of honey (14 monofloral and 18 multifloral) collected from the Algerian 
Sahara Desert against four bacteria; Bacillus subtilis, Clostridium perfringens, Escherichia coli 
and S. aureus. The research confirmed high antimicrobial activity of honeys collected from 
this region; however, only disc diffusion method was used by the authors. All floral origins 
of honey showed antimicrobial activity against S. aureus but with rather similar reactions 
(9–10.5 mm), except with P. persica-based honey, whose activity was only 6 mm [34]. High 
anti-staphylococcal potential of honeys was also confirmed for clinical isolates of these bacte-
ria, including MRSA strains. Effective inhibition of growth of MRSA isolates has been revealed 
in the case of mentioned above Chilean honey obtained from Ulmo tree [32], Malaysian mela-
leuca honey [35], some Thai honeys, especially from longan flower [36], Finland [37] and also 
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many other geographical regions. Moreover, some authors revealed high activity of honey in 
eradication MRSA infections using in vivo models [38]. Considering honey as a  therapeutic, 
antimicrobial agent the honey produced from the manuka bush (Leptospermum scoparium) 
indigenous to New Zealand and Australia deserves special attention. In contrast to major-
ity of other nectar and honeydew honeys, the crucial factor responsible for the bactericidal 
activity of manuka honey is high concentration of 1, 2-dicarbonyl compound—methylglyoxal 
(MGO) in this product. High acidity and sugar concentration as well as hydrogen peroxide 
generation play in this case supporting roles [39, 40]. As a consequence, antimicrobial activity 
of this honey is not affected by heat treatment, catalase or proteolytic enzymes (hydrolysing 
glucose oxidase) [37, 40]. Several investigations in vitro confirmed high bactericidal, including 
antistaphylococcal activity of this honey [e.g. 27, 33]. Jenkins and Cooper revealed synergistic 
action between manuka honey and some antibiotics against MRSA and P. aeruginosa strains 
isolated from wounds [41]. Moreover, manuka honey has been successfully used for treat-
ment of chronic wound infections caused by MRSA [42].
2.1.3. Perspectives and limitations of treatment staphylococcal infections with honey
From the point of view of possibilities of exploiting of the therapeutic potential of honey espe-
cially promising, and most realistic, seem to be application of this product as a component of 
wound dressing materials. Using honey to eliminate pathogens from infected wounds has a 
long tradition, which can be counted in hundred or even thousands of years. Currently, sev-
eral companies specialize in production of dressings containing honey. However, many tech-
nical problems still have to be solved: (1) elimination of indigenous flora of honey, especially 
spores, without thermal or chemical treatment—results in deactivation of glucose oxidase 
and loss of antimicrobial activity, (2) inhibition of natural process of crystallization of honey, 
(3) large diversity of antimicrobial activity of honey—only the honeys with certified anti-
bacterial activities should be used for medical applications. These problems could be partly 
solved by using manuka honey. However, research of many investigators revealed that many 
“classical honeys”—which activity is based mainly on the generation of hydrogen peroxide, 
exhibit even higher activity in comparison to manuka honey with a high content of methylg-
lyoxal—550 mg/L [27, 28, 33]. Thus, they are also good candidates to be used in clinical prac-
tice as a component of dressings, ointments and creams, or direct application on the surface of 
infected skin, sores, diabetic foot, or mucous, e.g. in the oral cavity or genital tract.
2.2. Propolis
2.2.1. Basic information
The bees collect four products: nectar and honeydew for production of honey (source of carbo-
hydrates), pollen (source of proteins) and propolis. Propolis is not a component of bees’ diet; 
however, it is absolutely necessary for the proper development of bee colonies. This product, 
which is also called bee glue, is a natural resinous substance produced from plants’ buds and 
exudates, modified by addition of bees’ salivary secretions and wax. Similarly, as in the case 
of honey, propolis is a product of complex chemical composition. Some of its ingredients 
mainly polyphenols and flavonoids exhibit high antimicrobial activity. As a consequence, it 
Frontiers in Staphylococcus Aureus208 aureus
is used as a hive disinfectant. Bees use propolis for elimination of pathogenic microorganisms 
from the walls of hive and cells of honeycomb, in which larvae develop (nest wells) and honey 
is stored [43]. It is important for prevention of development of such dangerous pathogens as 
Paenibacillus larvae, the bacteria responsible for American foulbrood, one of the most impor-
tant diseases of bees [44]. Some authors also suggest that components of propolis, at least 
partially, affect the growth of Varroa destructor—most damaging parasite affecting honeybee 
colonies [45]. Because of its antimicrobial activity, propolis is also used by bees for mum-
mification of larger pests such as mice invading the hive, which were killed as a result of the 
sting. Mummification prevents the decomposition of the body of the pest—development of 
pathogenic flora as well as generation of unpleasant odour. Due to its physical and chemical 
properties (high viscosity, low water solubility), propolis is also used as an important build-
ing material for sealing the hive or natural habitats of these insects (protection against wind or 
rain, stabilization of construction), which is also important for safety of bees’ colonies.
2.2.2. Possibilities of application of propolis in therapy of bacterial infections
Similarly to honey, propolis was widely used in traditional medicine. The detailed history 
of using propolis in medicine and a discussion of perspectives of its future application have 
been recently presented by Silva-Carvalho and coworkers [46]. The chemical composition 
of this product depends on many factors: the geographical region where it was collected 
(the species of plants which were available for bees), season, weather conditions and many 
other. Some significant correlations were found primarily in the case of chemical composi-
tion of propolis and place of its isolation. On this basis, several different types of propolis 
have been proposed, e.g. poplar propolis, birch, green, red, “Pacific” and “Canarian”. This 
classification still evaluates and new, different types of propolis are being recognized, e.g. 
Mediterranean or Portuguese [46]. At least, 13 different types of propolis have been identi-
fied in Brazil [47]. Because of differences in chemical composition the biological, including 
antibacterial, activity of different propolis samples may vary significantly. However, the 
carried out to date studies revealed that staphylococci and other Gram-positive bacteria are 
usually highly sensitive to this product collected in many different geographical locations. 
Propolis remains especially popular in the non-conventional medicine in Brazil as well as 
in other tropical countries, thus the product obtained in this region is well-characterized. 
The global market size of propolis was about 2300 tons in 2015 (it is established that it will 
increase to 2900 tons in 2021), and Brazil is the largest production and exporting country 
of this product (https://www.whatech.com/market-research/materials-chemicals/125806-
world-propolis-industry-trends-share-size-2021-forecast-report). High anti-staphylococcal 
activity of propolis sourced from State of Paraná, in Brazil, was observed by Pamplona-
Zomenhan and coworkers, the MIC
50
 and MIC
90
 for the 210 strains (162 MSSA and 48 
MRSA) were both 1420 μg/mL [48]. The results of investigations performed by the groups 
of Fidoralisi [49] and Santana [50] indicated that propolis extracts might be effective against 
mastitis-causing S. aureus. The group of Fidoralisi observed reduction in S. aureus growth 
on average, 1.5 and 4 log
10
 times at concentration of propolis 200 and 500 μg/mL, respec-
tively. At concentrations of 1000 μg/mL, all tested propolis samples reduced bacterial 
growth to zero [49]. The same effect was observed by Santana and coworkers, but only 
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in BHI (Brain Hearth Infusion) medium. The authors noticed that in milk the bactericidal 
dose was at least 20-fold greater [50]. Interesting results were also published by Suleman 
and colleagues [51]. Some of 39 South Africa propolis samples exhibited much higher anti-
staphylococcal activity in comparison to three tested samples of Brazilian propolis with 
MIC and MBC values of only 6 μg/mL [51]. Al-Waili and coworkers revealed that ethano-
lic extracts of propolis collected from Saudi Arabia (EEPS) and from Egypt (EEPE) effec-
tively inhibited the growth of antibiotic resistant E. coli, S. aureus and C. albicans in single 
and polymicrobial cultures [52]. Strong antioxidant and antibacterial activity of propolis 
sourced from three different areas of Sonoran Desert in northwestern Mexico were con-
firmed in the research of Velazquez group [53]. The MIC against S. aureus of the most active 
sample (coming from Ures) was 100 μg/mL [53]. An antimicrobial effect of propolis har-
vested from honeybees in subtropical eastern Australia was investigated by Massaro and 
coworkers. The two tested propolis crude, ethanolic extracts showed bactericidal effects 
against S. aureus ATCC 25923 reference strain at the concentrations of 0.37–2.04 mg/mL 
[54]. Propolis produced in many Asian and European apiaries is also effective in elimina-
tion of staphylococci. The number of publications presenting results of biological proper-
ties of propolis sourced from this region has evidentially increased during the last decade. 
Because of limited size of this chapter only selected investigations can be described herein. 
Some promising results regarding antistaphylococcal activity of ethanolic extract of Polish 
propolis (EEPP) against methicillin- sensitive S. aureus (MSSA) and methicillin-resistant S. 
aureus (MRSA) clinical isolates have been recently revealed by Wojtyczka and coworkers. 
The investigated EEPP displayed varying effectiveness against twelve S. aureus strains, with 
MIC in the range from 0.39 to 0.78 mg/mL, determined by broth microdilution method, and 
minimal bactericidal concentration (MBC) of the EEPP ranged from 0.78 to 3.13 mg/mL. 
The disk diffusion assay revealed also that EEPP-enhanced antistaphylococcal activity of 
eight classical antimicrobial antibiotics, namely: cefoxitin, clindamycin, tetracycline, tobra-
mycin, linezolid, trimethoprim+sulfamethoxazole, penicillin and erythromycin [55]. The 
same authors also investigated EEPP activity against biofilm-forming coagulase-negative 
Staphylococcus strains. The biofilm formation ability of all tested S. epidermidis strains was 
inhibited at EEPP concentrations ranging from 0.39 to 1.56 mg/mL [56].
Due to its health-promoting properties, propolis is widely used as a component of cosmetics, 
some food and beverages. In our opinion, these applications are not adequate to the biologi-
cal properties of this product. The results of many presented above studies clearly indicate 
that propolis is a promising antimicrobial agent. Moreover, many other biological activities 
of this product have been described, including antioxidant, antiviral, antitumor, antifungal 
and immunomodulatory properties [46]. Large diversity of its chemical composition and con-
sequently its biological activity eliminate propolis from clinical applications. Nevertheless, 
this limitation should be considered in therapy of serious, life-threatening infections (or other 
diseases), where the exact amount of biological active agent has to be used. Staphylococci are 
often responsible for many, not really serious, but bothersome infections. We would suggest 
more frequent use of propolis for treatment of this type of diseases. Currently, most of these 
infections are treated with antibiotics, which should be rather reserved for serious infections. 
It leads to the overuse of antibiotics and development of resistance phenomenon. In contrast 
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to antibiotics, propolis is a mixture of many antimicrobial components, thus development of 
resistance against this product (parallel resistance to all active constituents) is not possible. 
We also agree with other authors that it is necessary to continue research on correlation of 
biological activity and chemical composition of this product. Identification of crucial ingredi-
ents or their compositions could be used also for treatment serious, life-threatening diseases.
2.2.3. Other bee products: pollen and royal jelly
Investigation of antimicrobial activity of pollen, fermented pollen (bee bread) and royal jelly is 
not as popular as in the case of honey and propolis. However, several authors confirmed that 
these products also reveal some antimicrobial potential. Boukraa and coworkers revealed that 
MIC value for royal jelly against S. aureus is about 2% (v/v) [57], and the group of Gunaldi [58] 
when using this product obtained promising results in the preservation of implant-related 
infection in rats. The activity of royal jelly is probably a consequence of presence within com-
position of this product some peptides that inhibit growth of bacteria including members of 
the genus Staphylococcus [59].
Antimicrobial, antimutagenic, antioxidant and even anti-inflammatory activity of bee pollen 
(collected in Portugal and Spain) has been revealed in the research of Pascola and colleagues 
[60], and S. aureus was found as the most sensitive microorganism to the activity of these 
products. High antimicrobial activity of methanolic and ethanolic extracts of several mono-
floral Slovakian bee pollens was observed by the group of Fatracova-Sramkowa. S. aureus 
was found as most sensitive to the poppy pollen ethanolic extract. The most sensitive bac-
teria of rape bee pollen methanolic extract and sunflower ethanolic extract was Salmonella 
enterica [61].
2.2.4. Honey and other bee products as a source of bacteriocinogenic bacteria with bactericidal 
antistaphylococcal activity
However, bacteriocins are usually active against bacteria closely related to producing strain, 
but there are also many exceptions to this general rule, e.g. nisin, which is active against 
broad spectrum of Gram-positive bacteria [62]. Recently carried out research of the group of 
Prof. Worobo from Cornell University revealed that honey should be considered as a poten-
tial source of microorganisms producing promising antimicrobial compounds, especially 
bacteriocins [63]. The mentioned authors analyzed two Manuka honeys from New Zealand 
and six domestic honeys from US. The 2217 isolates out of 2398 strains (92.5%) exhibited 
activity at least against one of the tested microorganisms. Among all the bacterial indicator 
strains, Listeria monocytogenes had highest susceptibility (69%) to the various antimicrobial 
compounds produced by all active bacterial isolates (1655 out of 2398), whereas S. aureus 
showed the second highest susceptibility of all indicator microorganisms tested. Growth of 
this bacterium was inhibited by 66.9% of all the isolates (1605 out of 2398) [63]. The bacte-
rial isolate TH13 was found as an efficient producer of peptide compound with high activity 
against P. larvae spp. larvae, which are etiological agents of American Foulbrood. It is a dis-
ease of honeybees that results in the annihilation of the honeybee colony [64]. Another iso-
late, identified as Bacillus thuringiensis SF316, was shown to efficiently produced thuricin H, 
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a bacteriocin which strongly inhibits the growth of Bacillus cereus [65]. Thus, it was shown 
that antimicrobial activity of honey is attributed not only to hydrogen peroxide (formed by 
glucose oxidase originating from honeybees), antioxidant components or dimethyloglyoxal 
(in the case of Manuka honey), but also to microorganisms which are present in this product.
However, results of some successful investigations have been published the trials of isolation 
of bacteriocinogenic bacterial strains from honey and other than honeybee products were 
rarely carried out to date. In our opinion, especially, promising source of bacteria producing 
interesting bacteriocins could be fermented pollen—it is pollen which is collected by bees 
for the winter and early spring. The high antimicrobial activity of fermented pollen is the 
consequence of lactic acid bacteria (LAB) presence in this product, and the products of LAB 
metabolism—lactic acid, as well as bacteriocins.
3. Antibacterial activity of essential oils and plant extracts against S. aureus
Essential oils (EO) and their components are becoming increasingly popular as antimicrobial 
agents. They belong to the group of secondary metabolites that are enriched in compounds 
based on an isoprene structure and are called terpenes. They occur as di-, tri-, tetra-, hemi- and 
sesquiterpenes. The compounds that contain additional elements, usually oxygen, are termed 
terpenoids. Terpenes, terpenoids, as well as essential oils containing these substances exhibit 
antibacterial activity against broad spectrum of microorganisms including staphylococci [66].
One of the best characterized EO, which effectively inhibits growth of S. aureus, including 
MRSA isolates, is tea tree oil (TTO) derived mainly from the Australian native plant Melaleuca 
alternifolia. The antimicrobial activity of TTO is attributed mainly to its major component—
terpinen-4-ol, and α-terpineol which is present in a lower concentration [67]. Several groups 
of researchers have evaluated the activity of TTO against MRSA. Carson et al. examined 
64 MRSA isolates from Australia and the United Kingdom and showed that the MIC and 
MBC for the Australian isolates were 0.25 and 0.5% (v/v), respectively, while for the United 
Kingdom isolates were 0.312 and 0.625%, respectively [68]. The TTO has been also evaluated 
as an alternative decolonization agent for MRSA. The ointment and body wash containing 
4 and 5% of TTO, respectively, were found as more effective in eradication of MRSA car-
riers than classical therapies with using 2% mupirocin nasal ointment and triclosan body 
wash [69]. Carson and coworkers revealed that TTO and its main components compromise 
the cytoplasmic membrane of S. aureus [70]. The most important consequences of the dam-
ages of lipid bilayer are as follows: leakage of important cytoplasmic components, inhibi-
tion of respiration (leakage of potassium ions), loss of sodium chloride tolerance and some 
changes in cell morphology [70, 71]. TTO, terpinen-4-ol and α-terpineol showed strong activ-
ity against biofilm formed by S. aureus on biomaterials. Partial destruction of 24-h-old biofilms 
was achieved in the concentration 4–8 times greater than MIC after 1 h, whereas 2–4 × MIC 
was adequate to obtain 90% reduction metabolic activity of biofilm after 4 h of treatment 
[72]. The research of some authors showed transient decreases in antibiotic susceptibility in 
several bacteria that had been exposed to TTO. It raises concerns that TTO may hinder the 
effectiveness of conventional antibiotics and influence the development of resistance [73–75]. 
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However, recently Hammer et al. showed that the presence of TTO or terpinen-4-ol resulted 
in only minor changes in antibiotic susceptibility of S. aureus isolates that were serially sub-
cultured with sub-inhibitory TTO or terpinen-4-ol [76].
Promising results were also obtained in the investigation of antimicrobial potential of laven-
der oil (LO). The oil obtained from Lavandula angustifolia demonstrated in vitro activity against 
MRSA at concentration of <1% [77]. Several chemically characterized lavender oils were 
assessed for their antibacterial activity using the disc diffusion method. All tested lavender 
oils inhibited growth of both MSSA and MRSA with inhibition zones ranged from 8 to 30 mm 
in diameter at oil doses ranging from 1 to 20 μL, respectively [78]. Some significant differences 
in the chemical composition and antibacterial activity of LO, which mainly depend on the 
origin of the lavender samples, were observed in research carried out by different authors. 
For example, it was demonstrated that oil from lavender of Bulgarian origin, which contains 
51.1% linalool and 9.5% linalyl acetate as main components, was more effective against bac-
teria than oil originated from lavender sample of French origin containing 29.1% linalool and 
43.2% linalyl acetate. It is believed, however, that lavender oil may be useful, first and fore-
most, as a prophylactic or topical application for surface infection [79].
Another interesting, from the point of view of its antimicrobial properties, is Thymus essen-
tial oils (TOs). Its main chemical components are α-thujone, α-pinene, camphene, β-pinene, 
p-cymene, α-terpinene, linalool, borneol, β-caryophyllene, thymol and carvacrol [80]. Different 
chemotypes of the essential oil from the genus Thymus were distinguished based on the pres-
ence of chemical components [81]. The antimicrobial properties of TOs are related to their high 
content of carvacrol and thymol, which were identified as the most efficient against bacteria 
[80]. Using an agar dilution method, the MIC values for MSSA and MRSA were reported for 
carvacrol (0.015–0.03%, v/v) followed by thymol (0.03–0.06%, v/v) [82]. The Thymus essential 
oils blended, in which the principal components were thymol, linalool, terpinen-4-ol and 
α-terpinene, exhibited significant inhibitory and bactericidal effects against strains of epidemic 
MRSA. The mean MIC and MBC values for the oil blend was 0.3 and 0.6%, respectively, whereas 
for the linalool chemotype thyme oil the MIC and MBC values were 0.4 and 0.8%, respectively. 
In the disc diffusion assay, the essential oils blended resulted in the formation of mean zone of 
inhibition size of 34.8 mm, while linalool chemotype produced a mean zone of 20.7 mm [83].
Recently research of many authors showed also the antimicrobial activity of geranium 
oil (GO) against MRSA [84, 85]. Among 67 components of geranium oil from Pelargonium 
 graveolens Ait, citronellol, geraniol, nerol, citronellyl formate, isomenthone and linalool are the 
main constituents responsible for its biological activity. The research based on agar dilution 
method showed that the geranium oil had very strong activity against the clinical S. aureus 
strains, including MRSA strains, exhibiting MIC values of 0.25–2.50 μL/mL [85]. Moreover, 
Rosato et al. showed the occurrence of a synergism between geranium oil and norfloxacin 
against reference S. aureus strains [86].
The antibacterial activity of essential oils from oregano (Origanum vulgare) against multire-
sistant bacteria, including MRSA, was analysed by Costa et al. [87]. The MIC values were 
determined by the microdilution method. MRSA were inhibited by the essential oil at the 
 concentration of 0.125%. Nostro et al. investigated activity of essential oils from oregano 
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against biofilm-grown S. aureus and the effects of the oil on biofilm formation. The bio-
film inhibitory concentrations (0.125–0.500%, v/v) and biofilm eradication concentrations 
(0.25–1.0%, v/v) were twofold or fourfold greater than the concentration inhibitory plank-
tonic growth. Sub-inhibitory concentrations of the oils from oregano prevented biofilm 
formation by S. aureus strains [82].
Nigella sativa is a herbaceous plant cultivated in many countries in the world [88]. Crude 
extract and seed essential oil possess antibacterial activity against several bacteria [89]. The 
antibacterial effect may be due to the presence of the two important active compounds of 
N. sativa, thymoquinone and melanin [90]. The activity of N. sativa extract against clinical 
isolates MRSA was investigated by Hannan et al. [91]. They showed that all MRSA isolates 
were sensitive to N. sativa extract at a concentration of 4 mg/disc and MIC was in the range 
of 0.2–0.5 mg/mL. On the other hand, the multidrug resistant S. aureus strains isolated from 
nasal and milk samples of cows and buffalo were completely inhibited by N. sativa extract 
at concentration of 40 μg/mL on disc and MIC values were between 0.3 and 2.5 mg/mL [92].
Essential oil of cinnamon and cinnamaldehyde, which is main chemical constituent of this oil, 
also showed activity against MRSA. Essential oil from Cinnamomum osmophloeum (clone B) 
had an excellent inhibitory effect with the MIC of the essential oil and cinnamaldehyde 
against MRSA from human stand at 250 μg/mL [93]. The antimicrobial activity of cinnamon 
essential oil and trans-cinnamaldehyde against Staphylococcus spp. from clinical mastitis of 
cattle and goats was not dependent on the antibacterial susceptibility profile. However, the 
best antimicrobial activity was showed with trans-cinnamaldehyde and this compound could 
be used in the treatment of mastitis [94].
The number of research on antibacterial properties of extracts from medicinal plants against 
MRSA increased in recent years. These researches are conducted in different countries and 
show that extracts of plants are rich source of unique phytochemicals with activity against 
MRSA. Among recently investigated plant was Schinus areira L., which grows naturally in 
Argentina, Peru, Bolivia and Northern Chile. The essential oil from leaves and fruits of two 
specimens of S. areira differ in chemical profile. The limonene-rich oil isolated from the leaves 
and fruits had potent antibacterial effect on MRSA. When using 3.2 and 15 μL/mL (MICs 
value) of essential oil from leaves and fruits, respectively, the complete inhibition of MRSA 
growth was observed. Leaves and fruits oils showed bactericidal action after incubation for 
24 h with 20 and 40 μL/mL, respectively. On the other hand, the α-phellandrene-rich fruit oil, 
having a lower content of limonene, was inactive against MRSA [95].
According to research of Endo and Dias Filho [96], MRSA is also sensitive to berberine (plant 
alkaloid) which is used in Chinese medicine. MICs values of berberine ranged from 62.5 to 
250 μg/mL and MBC values were the same or twofold above the MIC. Highly potent anti-
MRSA activity with MIC values in range of 25–50 mg/mL was detected among Libyan medici-
nal plants such as Cistus salviifolius, Salvia officinalis, Pistacia atlantica, Arbutus pavarii and Myrtus 
communis [97]. Significant anti-MRSA activity was documented in many studies on extracts of 
plants used in traditional medicine in Brazil. A mixture of hydrolyzable tannins from Punica 
granatum and the naphthoquinones α-lapachone I and α-xyloidone II from Tabebuia avellanedae 
showed antibacterial activity against all S. aureus strains tested, including MRSA isolates [98]. 
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Turnera ulmifolia L. occurs in the north and northeast Brazilian regions and ethanol extract 
from this plant showed synergistic effect on gentamicin and kanamycin against MRSA strains. 
Coutinho et al. [99] found that the presence of ethanol extract of T. ulmifolia in growth medium 
at concentration of 32 μg/mL causes a significant reduction in the MIC for these antibiotics. 
The other studies conducted in India reported that ethanol, methanol and acetone extracts of 
Moringa oleifera, Elettaria cardamomum and Tamarindus indica seeds from India showed antibac-
terial activities against multidrug resistant MRSA isolates from wound infection [100].
4. Conclusions
Staphylococci belong to the most important pathogens for both humans and animals. The 
number of antibiotics effective in treatment of infections caused by these pathogenic bacteria 
is rapidly decreasing. Many centuries of observation and the use of bee products and essential 
oils in folk medicine as well as the results of advanced scientific research carried out dur-
ing the last several decades clearly confirm high antimicrobial, including antistaphylococcal 
activity of these products. We have no doubt that they are an interesting and promising alter-
native to classical antibiotics and should be more seriously considered as therapeutic agents.
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